Dry Powder Nebulization Formulations for Lower Respiratory Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments for respiratory tract conditions, particularly those affecting the lower respiratory tract, face challenges in targeted delivery of medications due to the complexity of respiratory tract anatomy and the varied nature of these conditions, which often require precise localization of treatment.
Innovation Solution
A method involving the formulation of a dry powder mixture containing beta agonists, anticholinergics, and other active ingredients, which is mixed with a sterile diluent and nebulized to deliver the composition directly to the lower respiratory tract, using small particle nebulization systems to ensure effective deposition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If systemic delivery routes such as oral or intravenous administration are used, then medication can reach multiple locations in the respiratory tract, but the precision of targeted delivery to specific areas is reduced
Solution Approach 1:
The invention segments the respiratory tract treatment by using multiple nebulization formulations with different particle size ranges (e.g., 1-5 microns for lower respiratory tract, 5-10 microns for upper respiratory tract). Each formulation is specifically designed to deposit in particular anatomical regions, allowing targeted delivery while maintaining the ability to treat multiple locations through sequential or combined administration of different segmented formulations.
2Manufacturing precision
If dry powder formulations are mixed with sterile diluent and nebulized, then delivery to the lower respiratory tract is enhanced, but the complexity of the administration process increases
Solution Approach 1:
The invention uses a sterile diluent as an intermediary substance to convert dry powder formulations into nebulizable suspensions. This intermediary step enables the medication to be delivered via nebulization to the lower respiratory tract while maintaining a relatively simple overall process that can be performed at the point of care without requiring complex manufacturing equipment.
3Manufacturing precision
If localized application of medications is used, then targeted treatment is achieved, but the ability to treat multiple respiratory conditions simultaneously is limited
Solution Approach 1:
The invention creates a universal treatment system where a single nebulization platform can deliver multiple different formulations targeting various respiratory tract regions. The system is designed to accommodate different active ingredients and particle size ranges in separate formulations that can be administered sequentially or in combination, allowing one device and methodology to treat multiple respiratory conditions simultaneously while maintaining localized precision for each condition.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the delivery of medications to the lower respiratory tract, increasing systemic bioavailability and treatment efficacy while minimizing side effects by targeting the precise treatment site.
Implementation Method 1
nebulizing the solution or suspension to generate particles
Data Source
AI summary
A method of making a pharmaceutical composition for delivery to the lower respiratory tract via nebulization within a sterile diluent includes mixing dry powder ingredients including a beta agonist or anticholinergic and one or more additional ingredients to formulate a dry powder mixture for mixing with the sterile diluent.